Supplementary Fig. 1 from Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma

MLA

Roberto Pili, et al. Supplementary Fig. 1 from Therapeutic Targeting of TFE3/IRS-1/PI3K/MTOR Axis in Translocation Renal Cell Carcinoma. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22470089.v1.

APA

Roberto Pili, Peter C. Hollenhorst, George M. Yousef, W. Marston Linehan, Chinghai Kao, Sreenivasulu Chintala, Ashley Orillion, May Elbanna, Remi Adelaiye-Ogala, Venkata Nithinsai Chintala, Khunsha Ahmed, Anthony C. Wood, Eric Kauffman, Sheng Yu Ku, Mary W. Ferris, Heba W.Z Khella, Justin A. Budka, & Nur P. Damayanti. (2023). Supplementary Fig. 1 from Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma. https://doi.org/10.1158/1078-0432.22470089.v1

Chicago

Roberto Pili, Peter C. Hollenhorst, George M. Yousef, W. Marston Linehan, Chinghai Kao, Sreenivasulu Chintala, Ashley Orillion, et al. 2023. “Supplementary Fig. 1 from Therapeutic Targeting of TFE3/IRS-1/PI3K/MTOR Axis in Translocation Renal Cell Carcinoma,” March. doi:10.1158/1078-0432.22470089.v1.